SCHEMBL5066977

SCHEMBL5066977

C=CC(=O)NC(=O)CCCCCCCC=CCCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.55
TERT O14746 3/20 0.54
PTPN1 P18031 3/20 0.54
PPARG P37231 3/20 0.54
PPARD Q03181 3/20 0.54
PPARA Q07869 3/20 0.54
KMT2A Q03164 3/20 0.54
CYP1A2 P05177 2/20 0.54
MAPT P10636 2/20 0.54
CYP2C19 P33261 2/20 0.54
BLM P54132 2/20 0.54
HSD17B10 Q99714 2/20 0.54
FABP4 P15090 2/20 0.54
FAAH O00519 2/20 0.54
MEN1 O00255 2/20 0.54
GMNN O75496 1/20 0.54
USP2 O75604 1/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
CYP2C9 P11712 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7718955 1.00 HRH3 (0.55) HRH3TERTPTPN1PPARGPPARD
SCHEMBL5830307 0.92 FAAH (0.58) KMT2AMAPTFAAHMEN1POLB
SCHEMBL3211607 0.92 FAAH (0.58) KMT2AMAPTFAAHMEN1POLB
SCHEMBL7710247 0.92 FAAH (0.58) KMT2AMAPTFAAHMEN1POLB
SCHEMBL4919984 0.92 FAAH (0.58) KMT2AMAPTFAAHMEN1POLB
SCHEMBL7710254 0.92 FAAH (0.58) KMT2AMAPTFAAHMEN1POLB
SCHEMBL15129341 0.92 FAAH (0.58) KMT2AMAPTFAAHMEN1POLB
SCHEMBL2931470 0.90 FAAH (0.55) KMT2AMAPTFAAHMEN1POLB
Ethylene SCHEMBL9763909 0.86 TERT (0.61) HRH3TERTPTPN1PPARGPPARD
Ethylene SCHEMBL28240386 0.86 TERT (0.61) HRH3TERTPTPN1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6379599-B1 Process for the preparation of molecularly imprinted polymers useful for separation of enzymes COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-04-30 US claimed
US-20260070874-A1 BENZOYLFORMIC ACID AMIDE DERIVATIVE KJ CHEMICALS CORPORATION (JP) 2026-03-12 US disclosed
EP-4610249-A1 BENZOYLFORMIC ACID AMIDE DERIVATIVE KJ Chemicals Corporation (JP) 2025-09-03 EP disclosed
US-20230391937-A1 POLYMERIZABLE COMPOSITION, PRODUCT OF POLYMERIZATION OF SAME, AND MOLDED ARTICLE OBTAINED USING THESE KJ CHEMICALS CORPORATION (JP) 2023-12-07 US disclosed
JP-2023161581-A METHOD FOR TREATING ORGANIC WASTEWATER CONTAINING AMIDE COMPOUND KJケミカルズ株式会社 2023-11-07 JP disclosed
EP-4230664-A1 POLYMERIZABLE COMPOSITION, PRODUCT OF POLYMERIZATION OF SAME, AND MOLDED ARTICLE OBTAINED USING THESE KJ Chemicals Corporation (JP) 2023-08-23 EP disclosed
CN-110709432-B Ethylene-based polymer and method for preparing same 陶氏环球技术有限责任公司 2022-09-23 CN disclosed
WO-2022080493-A1 POLYMERIZABLE COMPOSITION, PRODUCT OF POLYMERIZATION OF SAME, AND MOLDED ARTICLE OBTAINED USING THESE KJケミカルズ株式会社 2022-04-21 WO disclosed
CN-110709432-A Ethylene-based polymers and methods of making the same 陶氏环球技术有限责任公司 2020-01-17 CN disclosed
US-7347938-B2 Use of hydrophobically modified copolymers based on N-vinyl monomers for the production of membranes BASF AKTIENGESELLSCHAFT (DE) 2008-03-25 US disclosed
US-20050126987-A1 Use of hydrophobically modified copolymers based on n-vinyl monomers for the production of membranes BASF AKTIENGESELLSCHAFT (DE) 2005-06-16 US disclosed
EP-0859547-B1 VIRUS INACTIVATING COATINGS SURMODICS INC (US) 2003-09-17 EP disclosed
US-6436440-B1 Use of N-vinyllactam-or-N-vinylamine-containing copolymers as matrix for producing solid pharmaceutical and cosmetic presentations BASF AKTIENGESELLSCHAFT (DE) 2002-08-20 US disclosed
US-6379599-B1 Process for the preparation of molecularly imprinted polymers useful for separation of enzymes COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-04-30 US disclosed
EP-0859547-A4 VIRUS INACTIVATING COATINGS SURMODICS INC (US) 2000-12-20 EP disclosed
EP-0859547-A1 VIRUS INACTIVATING COATINGS BSI Corporation (US) 1998-08-26 EP disclosed
WO-1996039821-A1 VIRUS INACTIVATING COATINGS BSI CORPORATION (US) 1996-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391937-A1 POLYMERIZABLE COMPOSITION, PRODUCT OF POLYMERIZATION OF SAME, AND MOLDED ARTICLE OBTAINED USING THESE MTR, AHCY, MAT1A HRH3 699/4885TERT 650/4885PTPN1 1668/4885
US-20260070874-A1 BENZOYLFORMIC ACID AMIDE DERIVATIVE CRYAA, BCAT1, BRCA1 HRH3 2074/4885TERT 1660/4885PTPN1 2017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.